Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

US pharmaceutical firm Pfizer has sold off its remaining stake in Sensodyne and Panadol maker ... businesses of British ...

GSK's consumer health spinout Haleon started ... a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum ...

From the outset, both Pfizer and GSK were clear about their intentions to whittle down their holdings in Haleon, which markets a bevy of popular household brands such as Advil, Sensodyne ...

The Sensodyne-maker has confirmed that its chief ... However, Haleon – which was split out from GSK in 2022 – has now removed the gender diversity target for the coming year to “ensure ...

Under the deal, Sensodyne maker Haleon has agreed to buy ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival ... off its remaining stake in Sensodyne and Panadol maker Haleon ...